Protective effect of S-nitrosylated α1-protease inhibitor on hepatic ischemia-reperfusion injury

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 3, 2000, Pages 904-911

  Ikebe, Norisato ^a   Akaike, Takaaki ^a   Miyamoto, Yoichi ^a   Hayashida, Kazuyuki ^a   Yoshitake, Jun ^a   Ogawa, Michio ^a   Maeda, Hiroshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; HEME OXYGENASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; S NITROSOGLUTATHIONE; THIOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TISSUE BLOOD FLOW;

ALPHA 1-ANTITRYPSIN; ANIMALS; APOPTOSIS; CYTOPROTECTION; GLUTATHIONE; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; ISCHEMIA; L-LACTATE DEHYDROGENASE; LIVER; LIVER CIRCULATION; MALE; NEUTROPHILS; NITRIC OXIDE; NITROSO COMPOUNDS; RATS; RATS, WISTAR; REPERFUSION INJURY; S-NITROSOGLUTATHIONE;

EID: 0033696303     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Mechanisms of biological S-nitrosation and its measurement
2. Pathophysiological effects of high-output production of nitric oxide
3. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly
4. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
5. Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat
6. Nitric oxide decreases cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
7. Induction of haem oxygenase-1 by nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth
8. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury
9. Endothelium-derived relaxing and contracting factors
10. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways
11. Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion
12. 1-proteinase inhibitor
13. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle
14. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates
15. 1-protease inhibitor on hepatic ischemia-reperfusion injury
16. Nitrosothiol formation catalyzed by ceruloplasmin: Implication for cytoprotective mechanism in vivo
17. The role of neutrophils in myocardial ischemia-reperfusion injury
18. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances: Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus
19. Nitrogen oxide-induced autoprotection in isolated rat hepatocytes
20. S-Nitrosoglutathione improves functional recovery in the isolated rat heart after cardioplegic ischemic arrest: Evidence for a cardioprotective effect of nitric oxide
21. Nitric oxide: An endogenous modulator of leukocyte adhesion
22. Secretory leukocyte pretease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion
23. Inhibition of nitric oxide synthase attenuates peroxynitrite generation, but augments neutrophil accumulation in hepatic ischemia-reperfusion in rats
24. The heme oxygenase system: A regulator of second messenger gases
25. Fas-induced caspase denitrosylation
26. 1-protease inhibitor after S-nitrosylation: Inhibition of cysteine protease and antibacterial activity
27. 1-protease inhibitor
28. Esterase activity in leukocytes demonstrated by the use of napthol AS-D chloroacetate substrate
29. The L-arginine-nitric oxide pathway
30. In situ apoptotic cell labeling by the TUNEL method; Improvement and evaluation on cell preparations
31. Nitric oxide inhibits CPP32-like activity under redox regulation
32. Beneficial effects of FK409, a novel nitric oxide donor, on reperfusion injury of rat liver
33. Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation
34. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation
35. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP
36. Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress
37. Nitric oxide regulation of tissue free radical injury
38. Biochemistry of nitric oxide and its redox-activated forms
39. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat
40. Therapeutic effect of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity